https://www.selleckchem.com/products/AZD8055.html
Eighteen patients in the TMJOA group were retested after two HA treatments to evaluate the therapeutic effects of HA. IL-1β, IL-18, NLRP3 and CASP1 were all positive in the two groups, and TMJOA patients with condylar defects had higher expression of these molecules than TMJID patients (P 0.05). IL-1β, IL-18, and NLRP3 were decreased after two HA treatments (P0.05), but there was no significant difference in CASP1 after two HA injections (P = 0.549). The NLRP3 inflammasome signaling pathway may be involved in condylar degenerat